1117-AB83 202304 Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Medical Marijuana and Cannabidiol Research Expansion

Pursuant to Public Law 117-215, Medical Marijuana and Cannabidiol Research Expansion Act, passed on December 2, 2022, DEA plans on modifying its regulations related to the new application process and submission of supporting materials by electronic means only, through the Diversion Control Division secure online portal, for those who are manufacturing marijuana or cannabidiol for medical research and those who are conducting medical marijuana and cannabidiol research.

]]> Other Significant First Time Published in The Unified Agenda Proposed Rule Stage Undetermined Undetermined 21 CFR 1301 Pub. L. 117-215 No NPRM 10/00/2023 Final Action 12/00/2023 Docket Number DEA-1132 Undetermined Undetermined Undetermined Undetermined DPW@dea.gov www.regulations.gov No No Scott Brinks A. Section Chief, Regulatory Drafting and Support Section, Diversion Control Division 1117 Drug Enforcement Administration DEA 571 362-8209 scott.a.brinks@dea.gov 8701 Morrissette Drive, Springfield VA 22152